Hodgkin's lymphoma in adults: diagnosis, treatment and follow-up. - Wikidata - awgldk - TriplyDB

Hodgkin's lymphoma in adults: diagnosis, treatment and follow-up.

Hodgkin's lymphoma in adults: diagnosis, treatment and follow-up.

http://www.wikidata.org/entity/Q33406827

about

Hodgkin's lymphoma in adults: diagnosis, treatment and follow-up.

http://www.wikidata.org/entity/Q33406827

description

2013 nî lūn-bûn

@nan

2013 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մարտին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Hodgkin's lymphoma in adults: diagnosis, treatment and follow-up.

@ast

Hodgkin's lymphoma in adults: diagnosis, treatment and follow-up.

@en

type

label

Hodgkin's lymphoma in adults: diagnosis, treatment and follow-up.

@ast

Hodgkin's lymphoma in adults: diagnosis, treatment and follow-up.

@en

prefLabel

Hodgkin's lymphoma in adults: diagnosis, treatment and follow-up.

@ast

Hodgkin's lymphoma in adults: diagnosis, treatment and follow-up.

@en

P1433

Q33406827-F01BCA74-B9A9-48FA-A03D-6349FACB22AB

P1476

Q33406827-396A098A-ACC8-4258-8734-58D4EBEC7FB5

P2093

Q33406827-21C80912-7889-4FBE-A0AE-FED2919A34A9

Q33406827-48C44239-0C54-439A-9C54-15749AC38AC6

Q33406827-58202D6A-5C67-49FF-B320-BE05F9355A15

Q33406827-61CEFBEE-E42A-4692-AF7F-0F30FDE2BE43

Q33406827-FBAE13CA-E63C-492F-B33D-4EF118FED838

P2860

Q33406827-036ACC49-734A-4CCD-9AFF-D99F347F85A8

Q33406827-30238CDC-AB2B-4A0E-91B4-99546C82A349

Q33406827-422EEB84-710E-4A94-BD71-8A7B7C3E4B4A

Q33406827-491F355C-ECE6-46E2-AB51-E09A824087E9

Q33406827-6D9BDA32-EA4C-4384-A63A-FF621B35CCB8

Q33406827-6F2934C6-33E3-442F-8028-DE671CDD3EBE

Q33406827-711A7FB1-B86D-4F73-8283-2A58BCFA5A0C

Q33406827-74C3B67B-8786-4F58-940D-2E6EF5BEB9CC

Q33406827-8526F627-0F2B-4250-B596-CD02F852F048

Q33406827-8A462D91-8679-47C9-B4F4-3135C005D880

P304

Q33406827-A6B75780-C9F6-487C-B609-5D6B4582382D

P31

Q33406827-B392D3EF-0916-4197-817A-C1247514A581

P356

Q33406827-30847C8D-8545-4FE3-A1FC-55D58E0D55C4

P433

Q33406827-B7DE904A-26C5-433E-B925-B56490A9DD5C

P478

Q33406827-3D3FD293-79B6-4D61-B6E7-A17603579B55

P50

Q33406827-AC405937-A5BF-4BFE-8009-E0A727807040

P577

Q33406827-632798F3-39F0-43B0-B3B1-61A17F350AF6

P5875

Q33406827-DCE0562E-59A8-4946-BAE1-3F59D03646F9

P698

Q33406827-FE2E4724-5B9F-4EB1-9BCB-E9E44E85DBEA

P932

Q33406827-50D5B923-C34C-4B7F-AA42-54539ACC43A5

P356

ARZTEBL.2013.0177

P1433

Deutsches Ärzteblatt international

P1476

Hodgkin's lymphoma in adults: diagnosis, treatment and follow-up.

@en

P2093

Andreas Engert

http://www.w3.org/2001/XMLSchema#string

Bastian von Tresckow

http://www.w3.org/2001/XMLSchema#string

Karolin Behringer

http://www.w3.org/2001/XMLSchema#string

Michaela Rancea

http://www.w3.org/2001/XMLSchema#string

Teresa Halbsguth

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma

Dose-Intensification in Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD14 Trial

Time-intensified dexamethasone/cisplatin/cytarabine: an effective salvage therapy with low toxicity in patients with relapsed and refractory Hodgkin's disease.

Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial.

Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Study Group (GHSG).

Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trial.

Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial.

Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.

Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 t

Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial.

P304

177-83, 183e1-3

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3238/ARZTEBL.2013.0177

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-03-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236106187

http://www.w3.org/2001/XMLSchema#string

P698

23555321

http://www.w3.org/2001/XMLSchema#string

P932

3608228

http://www.w3.org/2001/XMLSchema#string